312 related articles for article (PubMed ID: 24519885)
1. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
2. TGF-β Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.
Asai K; Hisasue M; Shimokawa F; Funaba M; Murakami M
Biochem Genet; 2018 Oct; 56(5):542-552. PubMed ID: 29680988
[TBL] [Abstract][Full Text] [Related]
3. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
4. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
5. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
6. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
Shui C; Riggs BL; Khosla S
Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
8. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
Sharma SM; Sif S; Ostrowski MC; Sankar U
J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.
Kawamoto D; Ando-Suguimoto ES; Bueno-Silva B; DiRienzo JM; Mayer MP
Front Cell Infect Microbiol; 2016; 6():33. PubMed ID: 27064424
[TBL] [Abstract][Full Text] [Related]
10. Mitf regulates osteoclastogenesis by modulating NFATc1 activity.
Lu SY; Li M; Lin YL
Exp Cell Res; 2014 Oct; 328(1):32-43. PubMed ID: 25152440
[TBL] [Abstract][Full Text] [Related]
11. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.
Nagasawa T; Arai M; Togari A
Arch Oral Biol; 2011 Sep; 56(9):924-31. PubMed ID: 21377143
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages.
Canellada A; Custidiano A; Abraham F; Rey E; Gentile T
Placenta; 2013 Mar; 34(3):231-9. PubMed ID: 23347887
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
15. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.
Hu R; Sharma SM; Bronisz A; Srinivasan R; Sankar U; Ostrowski MC
Mol Cell Biol; 2007 Jun; 27(11):4018-27. PubMed ID: 17403896
[TBL] [Abstract][Full Text] [Related]
16. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
17. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz.
Hamamura K; Chen A; Tanjung N; Takigawa S; Sudo A; Yokota H
Cell Signal; 2015 Feb; 27(2):353-62. PubMed ID: 25435425
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]